DE69215375T2 - Verfahren zur reinigung von pentostatin - Google Patents

Verfahren zur reinigung von pentostatin

Info

Publication number
DE69215375T2
DE69215375T2 DE69215375T DE69215375T DE69215375T2 DE 69215375 T2 DE69215375 T2 DE 69215375T2 DE 69215375 T DE69215375 T DE 69215375T DE 69215375 T DE69215375 T DE 69215375T DE 69215375 T2 DE69215375 T2 DE 69215375T2
Authority
DE
Germany
Prior art keywords
pentostatin
eluting
applying
water
eluate
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
DE69215375T
Other languages
English (en)
Other versions
DE69215375D1 (de
Inventor
James French
Peter Mcdonnell
Howard Showalter
Colin Edmunds
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Warner Lambert Co LLC
Original Assignee
Warner Lambert Co LLC
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Warner Lambert Co LLC filed Critical Warner Lambert Co LLC
Publication of DE69215375D1 publication Critical patent/DE69215375D1/de
Application granted granted Critical
Publication of DE69215375T2 publication Critical patent/DE69215375T2/de
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44Non condensed pyridines; Hydrogenated derivatives thereof
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/65Tetracyclines
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00Medicinal preparations containing peptides
    • A61K38/04Peptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof
    • A61K38/05Dipeptides
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07HSUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H19/00Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof
    • C07H19/02Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof sharing nitrogen
    • C07H19/04Heterocyclic radicals containing only nitrogen atoms as ring hetero atom
    • C07H19/052Imidazole radicals

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • Epidemiology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Immunology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biochemistry (AREA)
  • Biotechnology (AREA)
  • Genetics & Genomics (AREA)
  • Molecular Biology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Peptides Or Proteins (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Steroid Compounds (AREA)
DE69215375T 1991-07-31 1992-07-16 Verfahren zur reinigung von pentostatin Expired - Lifetime DE69215375T2 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US73871591A 1991-07-31 1991-07-31
PCT/US1992/005946 WO1993003048A1 (en) 1991-07-31 1992-07-16 Process for purifying pentostatin

Publications (2)

Publication Number Publication Date
DE69215375D1 DE69215375D1 (de) 1997-01-02
DE69215375T2 true DE69215375T2 (de) 1997-03-13

Family

ID=24969187

Family Applications (1)

Application Number Title Priority Date Filing Date
DE69215375T Expired - Lifetime DE69215375T2 (de) 1991-07-31 1992-07-16 Verfahren zur reinigung von pentostatin

Country Status (15)

Country Link
US (1) US5463035A (de)
EP (1) EP0596943B1 (de)
JP (1) JP3141029B2 (de)
AT (1) ATE145404T1 (de)
AU (1) AU2381792A (de)
DE (1) DE69215375T2 (de)
DK (1) DK0596943T3 (de)
ES (1) ES2094919T3 (de)
GR (1) GR3022387T3 (de)
HU (1) HU215126B (de)
IE (1) IE80618B1 (de)
MX (1) MX9204460A (de)
PT (1) PT100755B (de)
WO (1) WO1993003048A1 (de)
ZA (1) ZA925732B (de)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1439220B1 (de) * 2003-01-16 2007-08-22 Adorkem Technology SpA Immobilisierte Biokatalysatoren für die Herstellung von natürlichen Nukleosiden und modifizierten Analogen durch enzymatische Transglykosylierungsreaktionen
ITMI20052516A1 (it) * 2005-12-29 2007-06-30 Evultis Sa PROCESSO PER L'ISOLAMENTO DI PèRINCIPI FARMACOLOGICAMENTE ATTIVI DI ORIGINE VEGETALE ED ANIMALE
CN101792722B (zh) * 2009-02-04 2013-04-10 杭州华东医药集团生物工程研究所有限公司 一种链霉菌及其应用
CN101798330A (zh) * 2009-02-06 2010-08-11 杭州华东医药集团生物工程研究所有限公司 一种喷司他丁的提取纯化方法
US20100261666A1 (en) * 2009-04-14 2010-10-14 The Board Of Trustees Of The University Of Illinois Compositions and methods for the treatment of myocardial dysfunction associated with sirs or sepsis
CN102453065B (zh) * 2010-10-29 2014-12-17 上海医药工业研究院 一种去除喷司他丁发酵液中杂质的方法

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3923785A (en) * 1974-04-22 1975-12-02 Parke Davis & Co (R)-3-(2-deoxy-{62 -D-erythro-pentofuranosyl)-3,6,7,8-tetrahydroimidazo{8 4,5-d{9 {8 1,3{9 diazepin-8-ol
US4713372A (en) * 1984-03-16 1987-12-15 Warner-Lambert Company 2-chloropentostatin compound having adenosine diaminase inhibitory activity
IT1182764B (it) * 1985-06-26 1987-10-05 Pietro Crocoli Water closet, particolarmente adatto per veicoli
US4935342A (en) * 1986-12-01 1990-06-19 Syngene, Inc. Method of isolating and purifying nucleic acids from biological samples
US4908441A (en) * 1988-07-19 1990-03-13 Warner-Lambert Company Deoxyadenosine compounds and methods of making and using the same

Also Published As

Publication number Publication date
ZA925732B (en) 1994-01-31
DE69215375D1 (de) 1997-01-02
HU9400257D0 (en) 1994-05-30
EP0596943B1 (de) 1996-11-20
DK0596943T3 (da) 1997-04-21
HU215126B (hu) 1998-09-28
PT100755B (pt) 1999-07-30
HUT65981A (en) 1994-08-29
JPH06509355A (ja) 1994-10-20
ATE145404T1 (de) 1996-12-15
ES2094919T3 (es) 1997-02-01
PT100755A (pt) 1993-10-29
WO1993003048A1 (en) 1993-02-18
IE80618B1 (en) 1998-10-21
EP0596943A1 (de) 1994-05-18
IE922507A1 (en) 1993-02-10
AU2381792A (en) 1993-03-02
GR3022387T3 (en) 1997-04-30
JP3141029B2 (ja) 2001-03-05
MX9204460A (es) 1993-04-01
US5463035A (en) 1995-10-31

Similar Documents

Publication Publication Date Title
PT99248A (pt) Processo para a purificcao de anticorpos
AU7571781A (en) Process for fermentative production of amino acids
DE69416594D1 (de) Verfahren zur herstellung von d-chiro inositol
EP0949632A3 (de) Verfahren zur Erzeugung von (F-18)-Fluoridion
CA2143280A1 (en) Separation of phytate from plant protein using ion exchange
DE69215375T2 (de) Verfahren zur reinigung von pentostatin
NZ226651A (en) Ion exchange protein separation method characterised by adjusting ph so that the pure protein and the impurity are oppositely charged
ES8207127A1 (es) Un procedimiento para recuperar betaina de melazas
EP0212688A3 (de) Substituierte und vernetzte Glukane, Verfahren zu deren Herstellung und ihre Verwendung
EP0428984B1 (de) Verfahren zur Trennung von Aminosäuren
ATE92460T1 (de) Verfahren zur rueckgewinnung der zitronensaeure aus fluessigkeiten, die sie enthalten.
IL125225A0 (en) Fsh and lh separation and purification process
GB1435063A (en) Preparation of beta-aminopropionitrile
EP0155384A3 (de) Methode zur Behandlung wässriger Lösungen mit schwach sauren Kationen- und basischen Anionen-Austauscherharzen
GB811688A (en) Method for purification of glutamic acid
EP0892045A3 (de) Verfahren zur Herstellung eines eine Hyaluronidase enthaltenden Präparats
US3173949A (en) Recovery of glutamic acid from a fermentation broth using cation exchange resins
MY109523A (en) Method of regenerating resin beads for use in water purification.
GB1201823A (en) Process for recovering glutamic acid
ES2004796A6 (es) Un procedimiento continuo para separar acidos a partir de una mezcla de acidos y sales de acidos correspondientes
TW260624B (en) Process of separating tryptophan (Trp) from zymotic fluid by ion-exchange displacement chromatography
FR2423987A1 (fr) Procede de preparation d'une substance proteinique a partir d'une levure, substance obtenue selon ce procede et son application dans le domaine de la nutrition
FR2424319A1 (fr) Procede de preparation de cytochrome c au moyen d'une levure
GB1198432A (en) Production of Caprolactam
GEP19971033B (en) Method of preparing lysozyme dimers

Legal Events

Date Code Title Description
8364 No opposition during term of opposition
R071 Expiry of right

Ref document number: 596943

Country of ref document: EP